Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
As research into GLP1 receptor agonists accelerates, leveraging cutting-edge fluorescent assay platforms is pivotal for producing robust, actionable pharmacological data
*Correspondence: Li Chen, [email protected] This article was submitted to Gut Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility
The firm pointed to the extensive gross-to-net adjustments that the manufacturers are already providing on these drugs. BMO Capital Markets, for its part, wrote in a note to investors, We reiterate that the important comparison remains the difference between the products newly discounted price and the products ultimate net price, including rebates, instead of their list prices
This gives people a new option for managing their weight under medical supervision
